Recce Pharmaceuticals (RCE.AU) Q1 2026 Earnings

27FebConfirmed
Q3 2024
Q1 2025
Q3 2025
Q1 2026
-0.06
-0.05
-0.04
-0.03

Details

Expected EPS
N/A
Actual EPS
-0.053728815345699836
Surprise EPS
-0.05
Surprise Percent
+∞%

Description

Recce Pharmaceuticals (RCE.AU) has reported earnings of -0.053728815345699836 per share for Q1 2026.

0 Comments

Share your thoughts